Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
about
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseasePreclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-MitoxyNovel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells.Low-variance RNAs identify Parkinson's disease molecular signature in bloodAge- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains.Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies.Defective autophagy in Parkinson's disease: lessons from genetics.Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays.Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation.Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein.
P2860
Q28068464-7A5C6FE2-324A-401A-BDAD-6F6D78071848Q28553993-6CEEA9E5-505D-4D9E-ADD8-90EEDB354244Q33889032-A7B985EC-D2A8-4477-9B2B-ECDEC1711700Q35630163-C49D5646-1B59-4A7D-9267-797F479420DDQ36962314-BF75C952-E654-4495-9D9B-69AD4C28AB9AQ37038032-8243AA0C-5390-4DE0-89F3-34D2ECE32EEAQ37277536-B4D63084-97AA-4CF6-B4AC-E9083A5A7E3EQ37307494-4607212C-B3D3-4C7D-920D-4D7A8F98F487Q38225786-5705EA7C-AEAE-4594-B0D9-A5783DD43DBDQ38614375-804AFA0C-8DDC-43A8-B00B-7B6F3EE81383Q39076065-3EBDD918-4CBF-4634-A9D0-56E003D7DE4DQ39146231-31689BD6-6023-4DDD-A91C-A63205A03B6EQ43089495-3578D125-C78A-4EC3-98E4-11A2230BC15FQ49509661-3A0CF9CE-2704-4B7C-8661-BF6EAB0E6F39Q55419948-E2AD35BE-458D-4883-B763-E6534D9232C5
P2860
Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@ast
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@en
type
label
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@ast
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@en
prefLabel
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@ast
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Lewy-like aggregation of α-syn ...... activity in vitro and in vivo.
@en
P2093
A B Singleton
E K Stachowski
R L Hamilton
T N M Alerte
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2012.01.028
P407
P577
2012-01-25T00:00:00Z